InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 39155

Saturday, 05/01/2021 12:53:08 PM

Saturday, May 01, 2021 12:53:08 PM

Post# of 44690
SHOULD NEURORX PURSUE ANOTHER LUNG-RELATED CLINICAL TRIAL???
[immune checkpoint inhibitor]-pneumonitis in a real-world lung cancer cohort is more common and severe than previously reported.

https://www.cancertherapyadvisor.com/home/cancer-topics/lung-cancer/pneumonitis-lung-cancer-immune-checkpoint-clinical-trial-treatment/

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

https://pubmed.ncbi.nlm.nih.gov/31310589/

INTESTINAL PEPTIDE HEALS LUNG

https://www.gesundheitsindustrie-bw.de/en/article/news/inhalation-intestinal-hormone-vip-helps-against-immunotherapy-induced-pneumonia